During the last session, Standard BioTools Inc (NASDAQ:LAB)’s traded shares were 4.04 million, with the beta value of the company hitting 1.65. At the end of the trading day, the stock’s price was $2.36, reflecting an intraday loss of -2.48% or -$0.06. The 52-week high for the LAB share is $3.16, that puts it down -33.9 from that peak though still a striking 38.14% gain since the share price plummeted to a 52-week low of $1.46. The company’s market capitalization is $904.00M, and the average trade volume was 2.07 million shares over the past three months.
Standard BioTools Inc (NASDAQ:LAB) trade information
Standard BioTools Inc (LAB) registered a -2.48% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -2.48% in intraday trading to $2.36, hitting a weekly high. The stock’s 5-day price performance is -7.09%, and it has moved by -10.61% in 30 days. Based on these gigs, the overall price performance for the year is 42.17%.
Standard BioTools Inc (LAB) estimates and forecasts
Statistics show that Standard BioTools Inc has outperformed its competitors in share price, compared to the industry in which it operates. Standard BioTools Inc (LAB) shares have gone up 7.76% during the last six months, with a year-to-date growth rate more than the industry average at 26.83% against 20.30.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 8.72%. While earnings are projected to return 62.14% in 2024.
LAB Dividends
Standard BioTools Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
